Moderna Inc.
MRNA | NASDAQ
$180.09
+$7.15 (+4.13%)
Sep 22, 2026, 12:19 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.72B | 1.91B | 2.6B | 1.13B | 1.28B | 1.62B | 1.93B | 1.64B | 2.48B | 2.05B | 2.91B | 2.93B | 3.8B | 3.44B | 3.21B | 3.03B | 2.87B | 5.05B | 6.85B | 5.55B | 5.6B | 5.44B |
Short-Term Investments | 3.42B | 3.3B | 3.2B | 3.37B | 3.85B | 4.35B | 5.1B | 5.22B | 6.01B | 6.47B | 5.7B | 4.64B | 4.66B | 5.48B | 6.7B | 5.32B | 5.02B | 5.07B | 3.88B | 3.36B | 2.39B | 2.29B |
Long-Term Investments | 1.93B | 2.41B | 2.34B | 2.25B | 2.38B | 2.42B | 2.51B | 2.36B | 2.36B | 3.69B | 4.74B | 5.36B | 6.22B | 7.53B | 8.36B | 8.66B | 10.16B | 9.17B | 6.84B | 6.44B | 4.21B | 468M |
Other Long-Term Assets | 213M | 263M | 421M | 241M | 359M | 368M | 407M | 440M | 516M | 502M | 523M | 478M | 1.07B | 981M | 946M | 52M | 87M | 94M | 46M | 15M | 13M | 12M |
Receivables | 103M | 147M | 284M | 1.39B | 457M | 306M | 592M | 1.84B | 423M | 387M | 1.08B | 2.15B | 688M | 1.52B | 1.69B | 2.82B | 2.84B | 3.36B | 3.32B | 3.2B | 2.07B | 3.23B |
Inventory | 280M | 146M | 153M | 332M | 240M | 128M | 117M | 412M | 399M | 295M | 202M | 487M | 715M | 732M | 949M | 2.08B | 1.92B | 1.94B | 1.44B | 965M | 643M | 494M |
Other Current Assets | 148M | 141M | 45M | 132M | 57M | 69M | 58M | 46M | 31M | 68M | 88M | 96M | 53M | 64M | 44M | 162M | 134M | 71M | 26M | 94M | 68M | 224M |
Total Current Assets | 5.82B | 5.77B | 6.54B | 6.6B | 6.17B | 6.77B | 8.1B | 9.67B | 9.66B | 9.6B | 10.33B | 10.8B | 10.6B | 12.12B | 13.43B | 14.3B | 13.56B | 16.35B | 16.07B | 13.43B | 10.97B | 11.7B |
Property-Plant & Equipment | 2.76B | 2.79B | 2.85B | 2.86B | 2.92B | 2.96B | 2.96B | 3.17B | 2.97B | 2.76B | 2.66B | 2.72B | 2.41B | 2.14B | 2.14B | 2.13B | 1.45B | 1.47B | 1.38B | 960M | 898M | 461M |
Goodwill & Intangibles | 161M | 168M | 97M | 99M | 100M | 101M | 92M | 93M | 94M | 95M | 96M | 97M | 98M | 100M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.15B | 5.72B | 5.79B | 5.54B | 5.84B | 5.94B | 6.04B | 6.14B | 6.02B | 7.13B | 8.1B | 8.65B | 11.29B | 12B | 12.43B | 11.76B | 12.48B | 11.26B | 8.6B | 7.5B | 5.18B | 991M |
Total Assets | 10.96B | 11.49B | 12.34B | 12.14B | 12.01B | 12.7B | 14.14B | 15.8B | 15.68B | 16.73B | 18.43B | 19.45B | 21.88B | 24.13B | 25.86B | 26.06B | 26.04B | 27.61B | 24.67B | 20.92B | 16.15B | 12.69B |
Account Payables | 167M | 161M | 317M | 267M | 175M | 226M | 405M | 373M | 279M | 183M | 520M | 494M | 310M | 389M | 487M | 330M | 181M | 199M | 302M | 87M | 77M | 8M |
Deferred Revenue | 295M | 102M | 99M | 163M | 218M | 125M | 153M | 379M | 702M | 559M | 568M | 1.37B | 1.04B | 1.22B | 2.04B | 4B | 4.09B | 5.6B | 6.25B | 7.98B | 7.3B | 7.53B |
Short-Term Debt | 52M | 50M | n/a | 48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 52M |
Other Current Liabilities | 1.83B | 1.97B | 1.57B | 893M | 654M | 666M | 863M | 665M | 758M | 834M | 842M | 491M | 141M | 104M | 243M | 434M | 378M | 108M | 140M | 117M | 128M | 817M |
Total Current Liabilities | 2.53B | 2.4B | 1.99B | 1.68B | 1.57B | 1.6B | 2.21B | 2.2B | 2.36B | 2.38B | 3.02B | 4.39B | 3.12B | 3.5B | 4.92B | 6.81B | 6.81B | 9.24B | 9.13B | 9.96B | 8.84B | 8.44B |
Long-Term Debt | 591M | 590M | 1.24B | 660M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 29M | 30M | -368M | -618M | 276M | 274M | 267M | 276M | 266M | 262M | 256M | 172M | 173M | 163M | 135M | 81M | 113M | 91M | 76M | 1M | 1M | 2M |
Total Long-Term Liabilities | 1.67B | 1.69B | 1.7B | 1.12B | 1.04B | 1.03B | 1.04B | 1.68B | 1.61B | 1.53B | 1.56B | 1.61B | 1.81B | 1.76B | 1.81B | 1.26B | 1.25B | 1.3B | 1.4B | 842M | 609M | 415M |
Total Liabilities | 4.2B | 4.08B | 3.69B | 2.81B | 2.61B | 2.64B | 3.24B | 3.88B | 3.97B | 3.91B | 4.57B | 6B | 4.94B | 5.26B | 6.74B | 8.06B | 8.06B | 10.53B | 10.52B | 10.8B | 9.45B | 8.86B |
Total Debt | 1.29B | 1.3B | 1.92B | 1.39B | 741M | 745M | 747M | 1.36B | 1.27B | 1.24B | 1.24B | 1.46B | 1.17B | 1.11B | 1.2B | 1.26B | 887M | 947M | 916M | 583M | 603M | 286M |
Book Value | 6.76B | 7.41B | 8.65B | 9.33B | 9.4B | 10.07B | 10.9B | 11.93B | 11.71B | 12.82B | 13.85B | 13.46B | 16.95B | 18.86B | 19.12B | 17.99B | 17.99B | 17.08B | 14.15B | 10.12B | 6.7B | 3.84B |
Book Value Per Share | 17.07 | 18.75 | 22.07 | 23.92 | 24.22 | 26.08 | 28.31 | 29.89 | 30.50 | 33.55 | 35.07 | 35.31 | 44.49 | 46.58 | 47.22 | 43.67 | 42.92 | 40.08 | 32.82 | 23.33 | 15.55 | 8.93 |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | 5.1B | 5.88B | 7.22B | 8.05B | 8.25B | 9.07B | 10.05B | 11.17B | 11.15B | 12.43B | 13.61B | 13.39B | 17.02B | 18.4B | 18.32B | 16.86B | 15.81B | 13.62B | 9.96B | 5.09B | 1.76B | -1.02B |
Comprehensive Income | 19M | 25M | 45M | 27M | 23M | 10M | -10M | 11M | -71M | -101M | -123M | -211M | -263M | -267M | -370M | -351M | -240M | -184M | -24M | 31M | 16M | 1M |
Shareholders Equity | 6.76B | 7.41B | 8.65B | 9.33B | 9.4B | 10.07B | 10.9B | 11.93B | 11.71B | 12.82B | 13.85B | 13.46B | 16.95B | 18.86B | 19.12B | 17.99B | 17.99B | 17.08B | 14.15B | 10.12B | 6.7B | 3.84B |
Total Investments | 5.35B | 5.71B | 5.55B | 5.62B | 6.23B | 6.78B | 7.61B | 7.58B | 8.37B | 10.16B | 10.44B | 10B | 10.88B | 13.01B | 15.06B | 13.98B | 15.19B | 14.24B | 10.72B | 9.8B | 6.59B | 2.76B |
Add to Watchlist
Select watchlists to add or remove MRNA